An embattled Bank of America executive was stripped of responsibility over a key money-making division — months after outcry over the headline-grabbing death of an overworked junior banker in ...

(Reuters) -Bank of America's third-quarter profit dropped as it paid more to customers to hold their deposits, but its earnings beat estimates, driven by investment banking and trading. The gains ...

Headquartered in Charlotte, North Carolina, Bank of America is one of the largest banks in the U.S. and offers a range of banking products, such as checking and savings accounts and certificates ...

BofA Investment Bankers, Traders Help Earnings Top Estimates Revenue from equity, FICC trading rises 12% to $4.93 billion Net interest income declines less than analysts had expected ...

(Reuters) - Bank of America reported a drop in third-quarter profit on Tuesday, as its income from customer interest payments shrank. Banks have been paying out higher interest rates amid intense ...

Bank of America is keeping its innovation streak rolling. Bank of America Corp. (NYSE: BAC) is keeping its innovation streak rolling — logging a 94% increase in artificial intelligence and ...

A BofA analyst sees room for Nvidia Corp. shares to tack on another 40% or so to their explosive rally, as a “generational opportunity” further unfolds. BofA’s Vivek Arya upped his price ...

Nvidia stock has much more room to run up its all-time high share price set this week, argue Bank of America analysts, who just meaningfully upped their price target for the artificial ...

Bitcoin is above $65,000. Even Trump Media is surging anew. All the signs of market froth are coming back, according to Bank of America’s latest fund manager survey. Investor optimism registered ...

a BofA survey of fund mangers published on Tuesday showed. Cash allocations dropped to 3.9% from 4.2% in September month, while equity allocations rose to a net 31% overweight, and bond ...

BofA also identified Pandora (OTC:PANDY), the streaming service owned by Sirius XM, as a weak spot, forecasting continued declines in active users and listening hours. Despite stabilization in the ...

BofA upgrades Tyra Biosciences from Neutral to Buy, raising price target to $31 from $22. TYRA-300 preclinical data shows 3-5% increase in bone length and a 5.88% foramen magnum expansion in mice ...